biote Corp.

BTMD Nasdaq CIK: 0001819253

Company Information

Industry Medicinal Chemicals & Botanical Products
SIC Code 2833
Entity Type operating
SEC Category Emerging growth company
Business Address 1875 W. WALNUT HILL LN #100, IRVING, TX, 75038
Mailing Address 1875 W. WALNUT HILL LN #100, IRVING, TX, 75038
Phone 972-486-9346
Fiscal Year End 1231
EIN 851791125

Financial Overview

FY2025

$27.05M
Net Income
$122.37M
Total Assets
$224.57M
Total Liabilities
-$58.54M
Stockholders' Equity
$39.34M
Cash & Equivalents

Recent SEC Filings

Form Type Date Filed Document
8-K Current report of material events April 3, 2026 View on SEC
4 Insider stock transaction report April 3, 2026 View on SEC
4 Insider stock transaction report April 3, 2026 View on SEC
DEF 14A Definitive proxy statement April 2, 2026 View on SEC
10-K Annual financial report March 13, 2026 View on SEC
8-K Current report of material events March 11, 2026 View on SEC
8-K Current report of material events January 26, 2026 View on SEC
10-Q Quarterly financial report November 7, 2025 View on SEC
8-K Current report of material events November 5, 2025 View on SEC
10-Q Quarterly financial report August 8, 2025 View on SEC

Annual Reports

10-K March 13, 2026
  • Achieved robust 28% revenue growth to $185 million in 2025, driven by increased pellet sales and dietary supplement revenue.
  • Turned around profitability significantly, reporting a net income of $22 million in 2025 from a $5 million net loss in 2024, with gross margins expanding to 72%.
View Analysis

Material Events

8-K Legal Issue January 26, 2026
High Impact
  • Biote's subsidiary, Asteria Health, initiated a voluntary recall of specific hormone pellets due to potential metal particles.
  • The company anticipates a one-time charge of $1.3 million in the fourth quarter of 2025 and another $1.0 million projected for 2026 for recall-related expenses.
View Analysis

Related Companies

Companies in the same industry (SIC: 2833)

Investor Resources

Learn more about SEC filings and how to research public companies.

Important Disclaimer

This AI-generated analysis is for informational purposes only and does not constitute financial or investment advice. Always consult with qualified professionals and conduct your own research before making investment decisions.